Archives: Agenda
Afternoon Networking & Refreshments
Panel Discussion Clinical Partnerships; transition and growth in an ever changing landscape
- Addressing the loss of innovative work due to biotechs ceasing to exist
- Discussing the increase in M&A (Mergers & Acquisitions)
- CRO hub’s role in managing various entities
Chair’s Closing Remarks & Drinks Reception Sponsored by KPS Life
Networking Lunch
CASE STUDY Effective strategies for pharma to engage naive sites in clinical research and development of site relationship manager
As an industry, it is essential to continuously bring on new sites and new physicians, ensuring they do not become a one-and-done site or Principal Investigator (PI). Therefore, Endo will share strategies to help sponsors find effective ways to guide naive sites on where to start in clinical research and support them every step of the way, from pre-study visits to study closure. Part of the strategies include the inclusion of a Site Relationship Manager role at Endo.
Global Virtual Clinical Trial Supplies: The Benefits of Implementing a Virtual Supply Strategy for Commercially Available Medications and Ancillary Supplies
- Optimize Employ Effort
- Minimize Waste and Risk
- Appreciate Significant Savings
- Sustainably Friendly
PANEL Choosing an outsourcing model: FSO vs FSP vs inhouse
- Weighing up pros and cons of different outsourcing models: which is best for your trial?
- When is mixing and matching better than fully outsourcing or keeping trials fully in house?
- Developing an outsourcing strategy as a small to medium sized biotech with limited resources
- Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?
- How do strategic alliances impact this decision?